Status:
COMPLETED
What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?
Lead Sponsor:
Murdoch Childrens Research Institute
Collaborating Sponsors:
Royal Children's Hospital
Conditions:
Invasive Pneumococcal Disease, Recurrent Isolated, 1
Invasive Pneumococcal Disease, Recurrent Isolated, 2
Eligibility:
All Genders
Up to 18 years
Brief Summary
This is a multicentre prospective audit to determine the incidence of immunodeficiency in children with IPD. Aims and/or research question of the project 1. To determine the incidence of primary imm...
Eligibility Criteria
Inclusion
- Children aged 0 to 18 years admitted to one of the six centres with IPD.
Exclusion
- Children who do not fulfil the age criteria for immunological evaluation at that particular site e.g. aged \<2 years at Royal Children's Hospital.
- Children with a known underlying condition predisposing to IPD i.e. nephrotic syndrome.
Key Trial Info
Start Date :
January 31 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT03815357
Start Date
January 31 2017
End Date
June 30 2021
Last Update
July 6 2022
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Sydney Children's Hospital
Sydney, New South Wales, Australia, 2031
2
Adelaide Women's and Children's Hospital
Adelaide, South Australia, Australia
3
Monash Health
Clayton, Victoria, Australia
4
Royal Children's Hospital
Melbourne, Victoria, Australia, 3049